Uncategorized

Filter posts by category

Smiling senior man reading a newspaper outdoors in a relaxed atmosphere.

Tebentafusp approved for eligible patients with advanced uveal melanoma in Scotland

Tebentafusp approved for eligible patients with advanced uveal melanoma in Scotland Ocular Melanoma UK has welcomed today’s decision by the Scottish Medicines Consortium (SMC) to approve tebentafusp (Kimmtrak®) for eligible adults with advanced uveal melanoma. The decision means tebentafusp is now available for prescribing on the NHS in Scotland for adults who are HLA-A*02:01 positive […]

Tebentafusp approved for eligible patients with advanced uveal melanoma in Scotland Read More »

CHEMOSAT update: NICE draft guidance and NHS England routine funding proposal

CHEMOSAT update: NICE draft guidance and NHS England routine funding proposal Ocular Melanoma UK Team and attendees at their recent parliamentary reception about securing timely access to treatment for rare cancers. Two Important Developments This Week Regarding CHEMOSAT for People with Ocular Melanoma That Has Spread to the Liver NHS England has launched stakeholder testing

CHEMOSAT update: NICE draft guidance and NHS England routine funding proposal Read More »